R&D Systems™ Recombinant Human FGF-18 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human FGF-18 Protein is derived from E. coli. The Recombinant Human FGF-18 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: O76093
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and Trehalose.
• Gene ID (Entrez): 8817
• Molecular Weight (g/mol): Observed M.W.: 19-24kDa, reducing conditions, Theoretical M.W.: 21kDa
• Quantity: 50 μg
• Source: E. coli-derived human FGF-18 protein Glu28-Ala207,with a N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: FGF18, FGF-18ZFGF5, fibroblast growth factor 18, zFGF5
• Common Name: FGF18
• Gene Symbol: FGF18
• Biological Activity: Measured in a cell proliferation assay using BaF3 mouse pro-B cells transfected with human FGF RIIIc. The ED50 for this effect is typically 4-24ng/mL
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: E. coli-derived Glu28-Ala207, with a N-terminal Met
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining